RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
NextCell Pharma Stock

NextCell Pharma P/S 2025

NextCell Pharma P/S

5.81

Ticker

NXTCL.ST

ISIN

SE0009723125

WKN

A2DSXP

As of May 28, 2025, NextCell Pharma's P/S ratio stood at 5.81, a -70.11% change from the 19.44 P/S ratio recorded in the previous year.

The NextCell Pharma P/S history

NextCell Pharma Aktienanalyse

What does NextCell Pharma do?

NextCell Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding NextCell Pharma's P/S Ratio

NextCell Pharma's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing NextCell Pharma's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating NextCell Pharma's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in NextCell Pharma’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about NextCell Pharma stock

What is the price-to-earnings ratio of NextCell Pharma?

The price-earnings ratio of NextCell Pharma is currently 5.81.

How has the price-earnings ratio of NextCell Pharma changed compared to last year?

The price-to-earnings ratio of NextCell Pharma has increased by -70.11% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of NextCell Pharma high compared to other companies?

Yes, the price-to-earnings ratio of NextCell Pharma is high compared to other companies.

How does an increase in the price-earnings ratio of NextCell Pharma affect the company?

An increase in the price-earnings ratio of NextCell Pharma would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of NextCell Pharma affect the company?

A decrease in the price-earnings ratio of NextCell Pharma would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of NextCell Pharma?

Some factors that influence the price-earnings ratio of NextCell Pharma are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does NextCell Pharma pay?

Over the past 12 months, NextCell Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, NextCell Pharma is expected to pay a dividend of 0 SEK.

What is the dividend yield of NextCell Pharma?

The current dividend yield of NextCell Pharma is .

When does NextCell Pharma pay dividends?

NextCell Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of NextCell Pharma?

NextCell Pharma paid dividends every year for the past 0 years.

What is the dividend of NextCell Pharma?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is NextCell Pharma located?

NextCell Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von NextCell Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of NextCell Pharma from 5/28/2025 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 5/28/2025.

When did NextCell Pharma pay the last dividend?

The last dividend was paid out on 5/28/2025.

What was the dividend of NextCell Pharma in the year 2024?

In the year 2024, NextCell Pharma distributed 0 SEK as dividends.

In which currency does NextCell Pharma pay out the dividend?

The dividends of NextCell Pharma are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von NextCell Pharma

Our stock analysis for NextCell Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NextCell Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.